Infection Control News

A study of patients on maintenance dialysis at a nonprofit national provider showed nearly a 25% mortality rate for those who contracted COVID-19.

In a virtual presentation, two members of the advanced practice provider team at Medstar Georgetown Transplant Institute in Washington, D.C., described their center’s experience with kidney transplantation throughout the COVID-19 pandemic.

Kidney care organizations and dialysis providers joined the CDC last week in efforts to assure dialysis clinic and transplant center staff that COVID-19 vaccinations are safe for themselves and their patients.

Researchers from Italy observed a “drastic” reduction in central venous catheter-related infections after hygienic procedures were implemented at hemodialysis facilities as a response to the COVID-19 pandemic.

KidneyX has set a Jan. 20 deadline for submissions to Round 2 of the COVID-19 Kidney Care Challenge.

U.S. Renal Care announced it is in the process of obtaining bamlanivimab, a monoclonal antibody therapy that has received emergency use authorization by the FDA for the treatment of mild-to-moderate COVID-19.

The National Kidney Foundation has released a statement urging the federal government to grant priority to patients with kidney disease and their contacts for receipt of COVID-19 vaccines.

Data from Italy indicate the impact of COVID-19 is not greater for children with chronic kidney disease or immunosuppression compared with a pediatric cohort who have neither condition.

An analysis of data from the United Network for Organ Sharing suggests the COVID-19 pandemic has had a significant impact on transplantation in the United States, especially in the initial months.

Researchers in the United Kingdom have determined that a widely available test is effective among patients with kidney disease for detection of an antibody that can develop after exposure to SARS-CoV-2.